According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032.
Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
"According to the latest report published by Data Bridge Market Research, the Chickenpox Vaccine Market
The global Chickenpox Vaccine market size was valued at USD 1.29 billion in 2024 and is projected to reach USD 1.78 billion by 2032, with a CAGR of 4.09% during the forecast period of 2025 to 2032.
Chickenpox Vaccine Market report has been framed by chewing over an array of market...
"Chickenpox Vaccine Market Summary:
According to the latest report published by Data Bridge Market Research, the Chickenpox Vaccine Market
The global Chickenpox Vaccine market size was valued at USD 1.29 billion in 2024 and is projected to reach USD 1.78 billion by 2032, with a CAGR of 4.09% during the forecast period of 2025 to 2032.
Chickenpox Vaccine Market analysis report...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek